Pentamidine/chlorpromazine

Drug Profile

Pentamidine/chlorpromazine

Alternative Names: Chlorpromazine/pentamidine; CRx-026

Latest Information Update: 23 Sep 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator CombinatoRx
  • Developer Zalicus
  • Class Antiemetics; Antineoplastics; Antiprotozoals; Antipsychotics; Benzamidines; Phenothiazines
  • Mechanism of Action Apoptosis stimulants; KIF11 protein inhibitors; Mitosis inhibitors; Phosphoric monoester hydrolase inhibitors; Protein-tyrosine-phosphatase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Solid tumours

Most Recent Events

  • 25 May 2007 CombinatoRx completes two phase I/II trials in late-stage or metastatic Solid tumours in the US
  • 21 Jul 2005 Pentamidine/chlorpromazine has been licensed to HenKan in Taiwan, China and South Korea
  • 20 Jul 2005 This programme is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top